Clinical Trial Update: Study to Evaluate the Efficacy and Safety of a Rilpivarine-based Antiretroviral Tratment Regimen in HIV- Infected Patients With Liver Metabolic Disease Who Maintain Udetectable HIV Viral Load [Phase 4]

View source ↗

Summary

A Phase 4 trial assessed the efficacy and safety of a rilpivirine-based antiretroviral regimen in HIV-infected patients with non-alcoholic fatty liver disease w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Edurant (rilpivirine)

Snippet

Sponsor: Fundacion SEIMC-GESIDA | Conditions: HIV Infections, Fatty Liver Disease | Phase 4 | Status: COMPLETED